Paul J Clancy - Net Worth and Insider Trading
Paul J Clancy Net Worth
The estimated net worth of Paul J Clancy is at least $19 Million dollars as of 2024-11-10. Paul J Clancy is the EVP, CFO of Alexion Pharmaceuticals Inc and owns about 93,309 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $17 Million. Paul J Clancy is also the Executive VP and CFO of Biogen Inc and owns about 10,813 shares of Biogen Inc (BIIB) stock worth over $2 Million. Details can be seen in Paul J Clancy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul J Clancy has not made any transactions after 2018-07-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul J Clancy
Paul J Clancy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul J Clancy owns 6 companies in total, including Incyte Corp (INCY) , Agios Pharmaceuticals Inc (AGIO) , and Alexion Pharmaceuticals Inc (ALXN) among others .
Click here to see the complete history of Paul J Clancy’s form 4 insider trades.
Insider Ownership Summary of Paul J Clancy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INCY | Incyte Corp | 2023-09-29 | director |
| AGIO | Agios Pharmaceuticals Inc | 2013-09-24 | director |
| ALXN | Alexion Pharmaceuticals Inc | 2019-07-11 | EVP & Chief Financial Officer |
 | | 2017-04-25 | Executive VP and CFO |
| | 2021-03-18 | director |
| | 2021-10-21 | director |
Paul J Clancy Latest Holdings Summary
Paul J Clancy currently owns a total of 2 stocks. Among these stocks, Paul J Clancy owns 93,309 shares of Alexion Pharmaceuticals Inc (ALXN) as of July 10, 2018, with a value of $17 Million and a weighting of 90.1%. Paul J Clancy also owns 10,813 shares of Biogen Inc (BIIB) as of April 25, 2017, with a value of $2 Million and a weighting of 9.9%.
Latest Holdings of Paul J Clancy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2018-07-10 | 93,309 | 182.50 | 17,028,893 |
| BIIB | Biogen Inc | 2017-04-25 | 10,813 | 173.02 | 1,870,865 |
Holding Weightings of Paul J Clancy
Paul J Clancy Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul J Clancy has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 5,241 shares on July 10, 2018, which brought Paul J Clancy around $687,148.
According to the SEC Form 4 filings, Paul J Clancy has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 9,892 shares on April 25, 2017, which brought Paul J Clancy around $3 Million.
Insider Trading History of Paul J Clancy
- 1
Paul J Clancy Trading Performance
Paul J Clancy Ownership Network
Ownership Network List of Paul J Clancy
Ownership Network Relation of Paul J Clancy
Paul J Clancy Owned Company Details
What does Incyte Corp do?
Who are the key executives at Incyte Corp?
Paul J Clancy is the director of Incyte Corp. Other key executives at Incyte Corp include See Remarks Barry P Flannelly , Principal Accounting Officer Thomas Tray , and EVP & General Manager & Europe Jonathan Elliott Dickinson .
Incyte Corp (INCY) Insider Trades Summary
Over the past 18 months, Paul J Clancy made no insider transaction in Incyte Corp (INCY). Other recent insider transactions involving Incyte Corp (INCY) include a net sale of 32,298 shares made by Barry P Flannelly , a net sale of 40,484 shares made by Steven H Stein , and a net sale of 3,324 shares made by Thomas Tray .
In summary, during the past 3 months, insiders sold 24,692 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 24,692 shares. During the past 18 months, 109,233 shares of Incyte Corp (INCY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 109,233 shares.
Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Incyte Corp Insider Transactions
Paul J Clancy Mailing Address
Above is the net worth, insider trading, and ownership report for Paul J Clancy. You might contact Paul J Clancy via mailing address: C/o Biogen Idec Inc., 14 Cambridge Center, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
